Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
Am J Gastroenterol ; 116(7): 1537-1541, 2021 07 01.
Article En | MEDLINE | ID: mdl-33955725

INTRODUCTION: We assessed if obesity perturbs the esophageal epithelial barrier function independent of promotion of gastroesophageal reflux (GER). METHODS: Thirty-eight participants were divided into 4 groups: Obesity-/GER-, Obesity+/GER-, Obesity-/GER+, and Obesity+/GER+. Esophageal intercellular space and desmosome density (structural integrity) and fluorescein leak (functional integrity) were measured. RESULTS: The Obesity+/GER- group demonstrated increased intercellular space, reduced desmosome density, and increased fluorescein leak compared with control subjects. These changes were similar but not additive to findings seen in Obesity-/GER + and Obesity+/GER+ patients. DISCUSSION: Central obesity impairs structural and functional integrity of the esophageal barrier independent of GER, likely predisposing to esophageal injury.


Esophageal Mucosa/metabolism , Extracellular Space , Gastroesophageal Reflux/metabolism , Obesity, Abdominal/metabolism , Permeability , Adult , Aged , Desmosomes/ultrastructure , Esophageal Mucosa/pathology , Esophageal Mucosa/ultrastructure , Female , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/pathology , Humans , Male , Middle Aged , Obesity, Abdominal/complications , Obesity, Abdominal/pathology
2.
Am J Gastroenterol ; 116(7): 1533-1536, 2021 07 01.
Article En | MEDLINE | ID: mdl-33734117

INTRODUCTION: Esophageal epidermoid metaplasia (EEM) is a rare disease. METHODS: Patients with EEM diagnosed between 2014 and 2020 were reviewed. RESULTS: Forty EEM cases were identified. EEM occurred in 9 (23%) patients before, concordant, or after esophageal squamous cell carcinoma (ESCC). EEM was associated with previous esophageal lichen planus in 5 patients, Barrett's esophagus 7, and esophageal adenocarcinoma 1. EEM was focal in 28 (70%) or diffuse in 12 (30%) and not detected in 45% on recent previous endoscopy. DISCUSSION: EEM is a premalignant underrecognized condition associated with multiple conditions. Close follow-up or endoscopic treatment may be warranted because of its ESCC association.


Esophageal Diseases/epidemiology , Esophageal Neoplasms/epidemiology , Esophageal Squamous Cell Carcinoma/epidemiology , Leukoplakia/epidemiology , Adenocarcinoma/epidemiology , Aged , Alcohol Drinking/epidemiology , Barrett Esophagus/epidemiology , Deglutition Disorders/physiopathology , Disease Progression , Endoscopy, Digestive System , Esophageal Diseases/pathology , Esophageal Diseases/physiopathology , Female , Gastroesophageal Reflux/epidemiology , Humans , Leukoplakia/pathology , Leukoplakia/physiopathology , Lichen Planus/epidemiology , Male , Metaplasia , Middle Aged , Tobacco Use/epidemiology
3.
Stem Cell Reports ; 8(2): 360-372, 2017 02 14.
Article En | MEDLINE | ID: mdl-28132886

Metabolism of oxidative stress is necessary for cellular survival. We have previously utilized the zebrafish as a model of the oxidative stress response. In this study, we found that gata1-expressing erythroid cells contributed to a significant proportion of total-body oxidative stress when animals were exposed to a strong pro-oxidant. RNA-seq of zebrafish under oxidative stress revealed the induction of tp53. Zebrafish carrying tp53 with a mutation in its DNA-binding domain were acutely sensitive to pro-oxidant exposure and displayed significant reactive oxygen species (ROS) and tp53-independent erythroid cell death resulting in an edematous phenotype. We found that a major contributing factor to ROS was increased basal mitochondrial respiratory rate without reserve. These data add to the concept that tp53, while classically a tumor suppressor and cell-cycle regulator, has additional roles in controlling cellular oxidative stress.


Erythroid Cells/metabolism , GATA1 Transcription Factor/genetics , Oxidative Stress , Tumor Suppressor Protein p53/genetics , Animals , Cell Death/genetics , Erythroid Cells/cytology , GATA1 Transcription Factor/metabolism , Gene Knockout Techniques , Gene Silencing , Mice , Mitochondria/genetics , Mitochondria/metabolism , Oxidation-Reduction , Oxidative Stress/genetics , Reactive Oxygen Species/metabolism , Tumor Suppressor Protein p53/metabolism , Zebrafish
4.
Development ; 138(13): 2693-703, 2011 Jul.
Article En | MEDLINE | ID: mdl-21613324

In insects, initiation of metamorphosis requires a surge in the production of the steroid hormone 20-hydroxyecdysone from the prothoracic gland, the primary endocrine organ of juvenile larvae. Here, we show that blocking TGFß/Activin signaling, specifically in the Drosophila prothoracic gland, results in developmental arrest prior to metamorphosis. The terminal, giant third instar larval phenotype results from a failure to induce the large rise in ecdysteroid titer that triggers metamorphosis. We further demonstrate that activin signaling regulates competence of the prothoracic gland to receive PTTH and insulin signals, and that these two pathways act at the mRNA and post-transcriptional levels, respectively, to control ecdysone biosynthetic enzyme expression. This dual regulatory circuitry may provide a cross-check mechanism to ensure that both developmental and nutritional inputs are synchronized before initiating the final genetic program leading to reproductive adult development. As steroid hormone production in C. elegans and mammals is also influenced by TGFß/Activin signaling, this family of secreted factors may play a general role in regulating developmental transitions across phyla.


Activins/metabolism , Neurosecretory Systems/metabolism , Transforming Growth Factor beta/metabolism , Animals , Blotting, Western , Drosophila , Ecdysteroids/metabolism , Endocrine Glands/metabolism , Fluorescent Antibody Technique , In Situ Hybridization , Insect Hormones/metabolism , Metamorphosis, Biological , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/genetics , Signal Transduction/physiology
5.
PLoS One ; 5(7): e11619, 2010 Jul 16.
Article En | MEDLINE | ID: mdl-20661280

The Sno oncogene (Snoo or dSno in Drosophila) is a highly conserved protein and a well-established antagonist of Transforming Growth Factor-beta signaling in overexpression assays. However, analyses of Sno mutants in flies and mice have proven enigmatic in revealing developmental roles for Sno proteins. Thus, to identify developmental roles for dSno we first reconciled conflicting data on the lethality of dSno mutations. Then we conducted analyses of wing development in dSno loss of function genotypes. These studies revealed ectopic margin bristles and ectopic campaniform sensilla in the anterior compartment of the wing blade suggesting that dSno functions to antagonize Wingless (Wg) signaling. A subsequent series of gain of function analyses yielded the opposite phenotype (loss of bristles and sensilla) and further suggested that dSno antagonizes Wg signal transduction in target cells. To date Sno family proteins have not been reported to influence the Wg pathway during development in any species. Overall our data suggest that dSno functions as a tissue-specific component of the Wg signaling pathway with modest antagonistic activity under normal conditions but capable of blocking significant levels of extraneous Wg, a role that may be conserved in vertebrates.


Drosophila Proteins/metabolism , Drosophila/growth & development , Drosophila/metabolism , Nuclear Proteins/metabolism , Signal Transduction/physiology , Transcription Factors/metabolism , Wings, Animal/growth & development , Wings, Animal/metabolism , Animals , Drosophila/genetics , Drosophila Proteins/genetics , Gene Expression Regulation, Developmental/genetics , Gene Expression Regulation, Developmental/physiology , Genotype , Immunohistochemistry , Microscopy, Confocal , Nuclear Proteins/genetics , Signal Transduction/genetics , Transcription Factors/genetics
...